Braidwell »

Vera Therapeutics shares owned by Braidwell

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by Braidwell

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 473k 29.06

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Vera Therapeutics

venBio Select Advisor
BlackRock
Kynam Capital Management
Deerfield Management Company
Vanguard Group
FMR
Eversept Partners
Sofinnova Ventures
State Street Corporation
Morgan Stanley
Integral Health Asset Management
Citadel Advisors
Pictet Asset Management Holding SA
Tang Capital Management
Geode Capital Management

View all funds holding Vera Therapeutics